Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of MR Microstructural Imaging Markers for Prostate Cancer Diagnosis and Investigation of the Associated Molecular Mechanisms

NCT07249281 is registered in ClinicalTrials.gov with First Affiliated Hospital of Zhejiang University as lead sponsor.

NCT NCT07249281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07249281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of MR Microstructural Imaging Markers for Prostate Cancer Diagnosis and Investigation of the Associated Molecular Mechanisms
Lead sponsor
First Affiliated Hospital of Zhejiang University
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2020
Completion date
December 31, 2028
Enrollment
2,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diffusion mri, prostate cancer